Comparable stake leader
BlackRock, Inc.
SEC ownership of Vanda Pharmaceuticals Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001347178.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
04 Jun 2026
- Public ticker
- VNDA on Nasdaq
- Parsed ownership sources
-
13F, 13D/G, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BlackRock, Inc.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
04 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001347178
- Issuer location
- Washington, DC
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Vanda Pharmaceuticals Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
04 Jun 2026
13F
13D/G
3/4/5
Lead comparable stake: 8.1%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 8.1%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
8.1%
STATE STREET CORP
5.1%
BlackRock Portfolio Management LLC
4.2%
MILLENNIUM MANAGEMENT LLC
2.8%
Mihael H. Polymeropoulos
4.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
8.1%
from 13D/G
|
$50,277,078
7,275,988 shares
|
— | 31 Mar 2026 |
| STATE STREET CORP |
13D/G
13F
STATE STREET CORPORATION · Company
|
5.1%
|
$20,837,533
3,015,562 shares
|
$0 | 31 Mar 2026 |
| BlackRock Portfolio Management LLC |
13D/G
|
4.2%
|
$17,333,652
2,508,488 shares
|
-$5,134,648 | 31 Mar 2026 |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
Company
|
2.8%
|
$14,808,391
1,679,013 shares
|
-$12,712,063 | 31 Dec 2025 |
| Mihael H. Polymeropoulos |
3/4/5
President and CEO, Director, Chairman of the Board
|
4.6%
|
$22,104,927
2,704,496 shares
|
-$1,235,471 | 02 Mar 2026 |
| Gunther Birznieks |
3/4/5
SVP, Business Development
|
0.84%
|
$4,084,982
494,197 shares
|
-$350,730 | 02 Mar 2026 |
| Kevin Patrick Moran |
3/4/5
SVP, CFO & Treasurer
|
0.7%
|
$3,405,231
412,015 shares
|
-$350,821 | 02 Mar 2026 |
| Timothy Williams |
3/4/5
SVP & General Counsel
|
0.64%
|
$3,119,963
377,450 shares
|
-$350,755 | 02 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$2,783,268.
Buys
$41,500
Insiders: 1
Sells
$2,824,768
Insiders: 6
Net
-$2,783,268
Shares: -334,342
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 10,000
Shares: 344,342
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 344,342 | $0 | $2,824,768 | -$2,824,768 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 10,000 | 0 | $41,500 | $0 | +$41,500 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-16 of 16 reporting-owner rows connected to Vanda Pharmaceuticals Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
16
Largest Forms 3/4/5 holder
Mihael H. Polymeropoulos
Net 12M change
-$2,783,267
Latest report
04 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Mihael H. Polymeropoulos | President and CEO, Director, Chairman of the Board | $22,104,927 | -$1,235,471 | -5.3% | Filing P/S | 02 Mar 2026 |
| Gunther Birznieks | SVP, Business Development | $4,084,982 | -$350,730 | -7.9% | Filing P/S | 02 Mar 2026 |
| Kevin Patrick Moran | SVP, CFO & Treasurer | $3,405,231 | -$350,821 | -9.3% | Mixed | 02 Mar 2026 |
| Timothy Williams | SVP & General Counsel | $3,119,963 | -$350,755 | -10% | Filing P/S | 02 Mar 2026 |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | $2,756,421 | -$254,590 | -8.5% | Filing P/S | 02 Mar 2026 |
| Richard W. Dugan | Director | $1,513,663 | Mixed | 04 Jun 2026 | ||
| Phaedra Chrousos | Director | $1,139,804 | Mixed | 04 Jun 2026 | ||
| Anne Sempowski Ward | Director | $1,110,208 | Mixed | 04 Jun 2026 | ||
| Tage Honore | Director | $933,326 | -$240,900 | -21% | Mixed | 04 Jun 2026 |
| Christos Vasilios Mihael Polymeropoulos | Senior VP, Medical Director | $863,750 | Mixed | 01 Apr 2026 | ||
| Stephen Ray Mitchell | Director | $779,765 | Mixed | 04 Jun 2026 | ||
| Daniel Patrick McGuire | SVP, GC and Secretary | $759,975 | Mixed | 04 Jun 2026 | ||
| Scott Laverne Howell | VP and Chief People Officer | $757,474 | Mixed | 01 Apr 2026 | ||
| Charles Cliff Duncan | Director | $682,023 | Mixed | 04 Jun 2026 | ||
| Aranthan S. Jones II | Chief Corp. Affairs Officer | $478,763 | Mixed | 15 Sep 2021 | ||
| Thomas Watkins | Director | $368,294 | Mixed | 02 Jun 2022 |
Recent insider transactions for Vanda Pharmaceuticals Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Daniel Patrick McGuire | VNDA | Common Stock | Award | 266.8% | 80,000 | 109,982 | 04 Jun 2026 | Direct | ||
| Phaedra Chrousos | VNDA | Common Stock | Award | 33.7% | 41,600 | 164,950 | 04 Jun 2026 | Direct | ||
| Charles Cliff Duncan | VNDA | Common Stock | Award | 72.8% | 41,600 | 98,701 | 04 Jun 2026 | Direct | ||
| Richard W. Dugan | VNDA | Common Stock | Award | 23.4% | 41,600 | 219,054 | 04 Jun 2026 | Direct | ||
| Anne Sempowski Ward | VNDA | Common Stock | Award | 34.9% | 41,600 | 160,667 | 04 Jun 2026 | Direct | ||
| Tage Honore | VNDA | Common Stock | Award | 44.5% | 41,600 | 135,069 | 04 Jun 2026 | Direct | ||
| Stephen Ray Mitchell | VNDA | Common Stock | Award | 58.4% | 41,600 | 112,846 | 04 Jun 2026 | Direct | ||
| Stephen Ray Mitchell | VNDA | Common Stock | Gift | -26.6% | -25,836 | 71,246 | 18 May 2026 | Direct | ||
| Charles Cliff Duncan | VNDA | Common Stock | Award | 57,101 | 57,101 | 22 Apr 2026 | Direct | |||
| Timothy Williams | VNDA | Common Stock | Sale | -10.1% | $350,755 | $8.27 | -42,434 | 377,450 | 02 Mar 2026 | Direct |
| Kevin Patrick Moran | VNDA | Common Stock | Sale | -9.35% | $350,821 | $8.27 | -42,442 | 411,380 | 02 Mar 2026 | Direct |
| Joakim Wijkstrom | VNDA | Common Stock | Sale | -8.46% | $254,590 | $8.27 | -30,800 | 333,469 | 02 Mar 2026 | Direct |
| Mihael H. Polymeropoulos | VNDA | Common Stock | Sale | -5.46% | $1,276,971 | $8.17 | -156,235 | 2,704,496 | 02 Mar 2026 | Direct |
| Gunther Birznieks | VNDA | Common Stock | Sale | -7.91% | $350,730 | $8.27 | -42,431 | 494,197 | 02 Mar 2026 | Direct |
| Tage Honore | VNDA | Common Stock | Sale | -24.3% | $240,900 | $8.03 | -30,000 | 93,469 | 23 Feb 2026 | Direct |
| Joakim Wijkstrom | VNDA | Common Stock | Award | 52.2% | 125,000 | 364,269 | 18 Feb 2026 | Direct | ||
| Gunther Birznieks | VNDA | Common Stock | Award | 30.4% | 125,000 | 536,628 | 18 Feb 2026 | Direct | ||
| Timothy Williams | VNDA | Common Stock | Award | 42.4% | 125,000 | 419,884 | 18 Feb 2026 | Direct | ||
| Kevin Patrick Moran | VNDA | Common Stock | Award | 38% | 125,000 | 453,822 | 18 Feb 2026 | Direct | ||
| Mihael H. Polymeropoulos | VNDA | Common Stock | Award | 22.5% | 525,000 | 2,860,731 | 18 Feb 2026 | Direct | ||
| Mihael H. Polymeropoulos | VNDA | Common Stock | Purchase | 0.43% | $41,500 | $4.15 | 10,000 | 2,335,731 | 07 Aug 2025 | Direct |
* marks a reported price that did not pass the local price check.